Analyst firms · Jefferies · GSK

Jefferies GSK price target and rating history

GSK plc (GSK) · Health Care

Jefferies rates GSK plc (GSK) Hold with a $55.90 price target, as of its latest action on Oct 29, 2026. It has published 4 rating actions on GSK since September 2022, including 1 upgrade and 3 downgrades.

Current rating

Hold

Price target

$55.90

Median target, all firms

Too few

Actions on GSK

4

Jefferies price target on GSK

Every Jefferies rating on GSK

• Oct 29, 2026
  DowngradeJefferies downgrades to Hold from Buy, price target $55.90
• Nov 12, 2024
  DowngradeJefferies downgrades to Hold from Buy, price target $53 to $39.50
• Jan 3, 2024
  UpgradeJefferies upgrades to Buy from Hold, price target $48
• Sep 8, 2022
  DowngradeJefferies downgrades to Hold from Buy, price target $50.50 to $34

How other firms rate GSK

Each firm's latest rating and stated target in the last 12 months.

Questions about Jefferies and GSK

What is Jefferies's price target for GSK?

Jefferies's latest stated price target for GSK plc (GSK) is $55.90, from its action on Oct 29, 2026.

What is Jefferies's rating on GSK?

Jefferies rates GSK Hold, a neutral rating, as of Oct 29, 2026.

When did Jefferies last change its view on GSK?

On Oct 29, 2026, Jefferies downgrades to Hold from Buy, price target $55.90.

More GSK rating histories

• Citigroup4
• Morgan Stanley3
• Deutsche Bank3
• UBS3

All Jefferies ratingsGSK news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.